References
Ng-Cheng-Hin B, O’Hanlon-Brown C, Alifrangis C, Waxman J (2011) Langerhans cell histiocytosis: old disease new treatment. QJM 104(2):89–96
Donadieu J, Chalard F, Jeziorski E (2012) Medical management of langerhans cell histiocytosis from diagnosis to treatment. Expert Opin Pharmacother 13(9):1309–1322
Safali M, McCutcheon JM, Wright DH (1997) Langerhans cell histiocytosis of lymph nodes: draining a papillary carcinoma of the thyroid. Histopathology 30(6):599–603
Patten DK, Wani Z, Tolley N (2012) Solitary langerhans histiocytosis of the thyroid gland: a case report and literature review. Head Neck Pathol 6(2):279–289
Xia CX, Li R, Wang ZH, Lv FJ, Tang XQ, Li QF, Zhang SH (2012) A rare cause of goiter: Langerhans cell histiocytosis of the thyroid. Endocr J 59(1):47–54
Goldstein N, Layfield LJ (1991) Thyromegaly secondary to simultaneous papillary carcinoma and histiocytosis X. Report of a case and review of the literature. Acta Cytol 35(4):422–426
Thompson LD (1996) Langerhans cell histiocytosis isolated to the thyroid gland. Eur Arch Otorhinolaryngol 253(1–2):62–65
Saiz E, Bakotic BW (2000) Isolated Langerhans cell histiocytosis of the thyroid: a report of two cases with nuclear imaging-pathologic correlation. Ann Diagn Pathol 4(1):23–28
Foulet-Rogé A, Josselin N, Guyetant S, Gardet JJ, Besancon A, Saint-André JP, Fabiani B (2002) Incidental langerhans cell histiocytosis of thyroid: case report and review of the literature. Endocr Pathol 13(3):227–233
Burnett A, Carney D, Mukhopadhyay S, Scalzetti EM, Leino D, Souid AK (2008) Thyroid involvement with Langerhans cell histiocytosis in a 3-year-old male. Pediatr Blood Cancer 50(3):726–727
Jamaati HR, Shadmehr MB, Saidi B, Khosravi A, Arab M, Mohammadi F (2009) Langerhans cell histiocytosis of the lung and thyroid, co-existing with papillary thyroid cancer. Endocr Pathol 20(2):133–136
Vergez S, Rouquette I, Ancey M, Serrano E, Caron P (2010) Langerhans cell histiocytosis of the thyroid is a rare entity, but an association with a papillary thyroid carcinoma is often described. Endocr Pathol 21(4):274–276
Ceyran AB, Senol S, Bayraktar B, Ozkanlı S, Cinel ZL, Aydın A (2014) Langerhans cell histiocytosis of the thyroid with multiple cervical lymph node involvement accompanying metastatic thyroid papillary carcinoma. Case Rep Pathol 2014:184237
Gordon MS, Gordon MB (2016) Occult Langerhans cell histiocytosis presenting with papillary thyroid carcinoma, a thickened pituitary stalk and diabetes insipidus. Case Rep Endocrinol 2016:5191903
AlZahrani R, Algarni M, Alhakami H, AlSubayea H, Alfattani N, Guler M, Satti M (2016) Thyroid Langerhans cell histiocytosis and papillary thyroid carcinoma. Gland Surg 5(5):537–540
Wu X, Chen S, Zhang LY, Luo YP, Jiang Y, Feng RE (2017) Langerhans cell histiocytosis of the thyroid complicated by papillary thyroid carcinoma: a case report and brief literature review. Medicine (Baltimore) 96(35):e7954
Al Hamad AM, Albisher HM, Al Saeed WR, Almumtin AT, Allabbad FM, Shawarby AM (2019) BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: a case report and literature review. BMC Cancer 19(1):170
Moschovi M, Adamaki M, Vlahopoulos S, Rodriguez-Galindo C (2015) Synchronous and metachronous thyroid cancer in relation to Langerhans cell histiocytosis; involvement of V600E BRAF-mutation? Pediatr Blood Cancer 62(1):173–174
Hershkovitch D, Avril MF, Bosq J, Caillou B, Nguyen T, Hayat M, Schlumberger M, Travagli JP, Desvignes V, Guillaume JC (1989) Generalized histiocytosis X in adults. Association with cancer of the thyroid. Ann Dermatol Venereol 116(11):875–878
Dong Hae Chung SYH, Cho HY, Kim NR, An JS, Lee Y-D, Park S (2012) Langerhans cell histiocytosis in the thyroid and draining lymph nodes: a case report. Endocrinol Metab 27(2):138–141
Abla O, Egeler RM, Weitzman S (2010) Langerhans cell histiocytosis: current concepts and treatments. Cancer Treat Rev 36(4):354–359
Rizzo FM, Cives M, Simone V, Silvestris F (2014) New insights into the molecular pathogenesis of langerhans cell histiocytosis. Oncologist 19(2):151–163
Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D (2003) BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95(8):625–627
Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM et al (2013) Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 309(14):1493–1501
Ascierto PA, Kirkwood JM, Grob JJ, Simeone E, Grimaldi AM, Maio M, Palmieri G, Testori A, Marincola FM, Mozzillo N (2012) The role of BRAF V600 mutation in melanoma. J Transl Med 10:85
Lupi C, Giannini R, Ugolini C, Proietti A, Berti P, Minuto M, Materazzi G, Elisei R, Santoro M, Miccoli P et al (2007) Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab 92(11):4085–4090
Kurtulmus N, Duren M, Ince U, Cengiz Yakicier M, Peker O, Aydın O, Altiok E, Giray S, Azizlerli H (2012) BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness. Endocrine 42(2):404–410
Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G et al (2005) BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 90(12):6373–6379
Kim YS, Kim JS, Bae JS, Park WC (2013) Clinical implication of the BRAFV600E mutation in papillary thyroid carcinoma. World J Surg Oncol 11:99
Gandolfi G, Sancisi V, Torricelli F, Ragazzi M, Frasoldati A, Piana S, Ciarrocchi A (2013) Allele percentage of the BRAF V600E mutation in papillary thyroid carcinomas and corresponding lymph node metastases: no evidence for a role in tumor progression. J Clin Endocrinol Metab 98(5):E934–E942
Dağlar-Aday A, Toptaş B, Oztürk T, Seyhan F, Saygili N, Eronat AP, Akadam-Teker B, Yilmaz-Aydoğan H, Aksoy F, Oztürk O (2013) Investigation of BRAF V600E mutation in papillary thyroid carcinoma and tumor-surrounding nontumoral tissues. DNA Cell Biol 32(1):13–18
Kumar R, Angelini S, Snellman E, Hemminki K (2004) BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol 122(2):342–348
Makras P, Samara C, Antoniou M, Zetos A, Papadogias D, Nikolakopoulou Z, Andreakos E, Toloumis G, Kontogeorgos G, Piaditis G et al (2006) Evolving radiological features of hypothalamo-pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH). Neuroradiology 48(1):37–44
Haupt R, Nanduri V, Calevo MG, Bernstrand C, Braier JL, Broadbent V, Rey G, McClain KL, Janka-Schaub G, Egeler RM (2004) Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 42(5):438–444
Prosch H, Grois N, Prayer D, Waldhauser F, Steiner M, Minkov M, Gadner H (2004) Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis. Pediatr Blood Cancer 43(5):594–599
Kaltsas GA, Powles TB, Evanson J, Plowman PN, Drinkwater JE, Jenkins PJ, Monson JP, Besser GM, Grossman AB (2000) Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 85(4):1370–1376
Makras P, Piaditis G, Kaltsas GA (2007) Systemic and endocrine manifestations of Langerhans’ cell histiocytosis: current concepts in diagnosis and management. Expert Rev Endocrinol Metab 2(6):773–783
Héritier S, Emile JF, Barkaoui MA, Thomas C, Fraitag S, Boudjemaa S, Renaud F, Moreau A, Peuchmaur M, Chassagne-Clément C et al (2016) BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy. J Clin Oncol 34(25):3023–3030
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
We had informed consent from patients.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ozisik, H., Yurekli, B.S., Demir, D. et al. Langerhans cell histiocytosis of the thyroid together with papillary thyroid carcinoma. Hormones 19, 253–259 (2020). https://doi.org/10.1007/s42000-020-00181-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42000-020-00181-2